| Application no. and date | 05702261.8 (espacenet) (Federated) (European Patent Register), 20050113 | | Patent/reg. no. and date | DK/EP 1713477, 20081001 | | Publication date | 20061025 | | Priority no. and date | GB 0402491, 20040204, US 545663 P, 20040217 | | EP pub. no. and date |
EP 1713477 20061025 | | Effective date | | | Applicant/owner | Pfizer Inc., 235 East 42nd Street
New York NY 10017, US | | Applicant ref. no. | P80829235DK00E | | Inventor | HUMPHREY, Michael John, Pfizer Global Research & Dev.,
Ramsgate Road
Sandwich,
Kent CT13 9NJ, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4196 (2006.01) , A61K 31/506 (2006.01) , A61P 31/00 (2006.01) | | Title | Forbindelse af voriconazol og en antisvampe CYP2C19 inhibitor | | Int. application no. | IB2005000098 | | Int. publication no. | WO2005084671 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
